Tag:

endometriosis

Health

New imaging agent shows promise for non-invasive endometriosis diagnosis

by Chief Editor
written by Chief Editor

Recent Imaging Agent Offers Hope for Earlier Endometriosis Diagnosis and Personalized Treatment

A novel molecular imaging agent, 99mTc-maraciclatide, is showing significant promise in revolutionizing the diagnosis and management of endometriosis, a chronic and often debilitating condition affecting millions of women worldwide. Recent Phase 2 trial data, published in The Lancet Obstetrics and Gynaecology, suggests the agent could provide a non-invasive alternative to laparoscopic surgery for detecting endometriosis, particularly the often-overlooked superficial peritoneal endometriosis (SPE).

The Challenge of Diagnosing Endometriosis

Endometriosis occurs when tissue similar to the lining of the uterus grows outside of it, causing inflammation and pain. Diagnosis currently relies heavily on laparoscopic surgery, an invasive procedure with associated risks and costs. SPE, present in approximately 80% of diagnosed cases, is notoriously difficult to identify even with surgery, leading to significant diagnostic delays. These delays can have a profound impact on a patient’s quality of life and fertility.

How 99mTc-maraciclatide Works

99mTc-maraciclatide is a radiotracer that targets αvβ3 integrin, a protein upregulated during angiogenesis – the formation of new blood vessels. Angiogenesis is a key characteristic of endometriosis lesions. By visualizing the uptake of this tracer using SPECT-CT imaging, clinicians can potentially identify endometriosis lesions without the need for surgery. The DETECT study represents the first apply of this agent for visualizing and diagnosing endometriosis.

Key Findings from the DETECT Study

The Phase 2 DETECT study demonstrated a strong correlation between areas where the imaging agent accumulated and the location of endometriosis lesions confirmed by laparoscopy. Specifically, imaging results aligned with surgical findings in 16 out of 19 cases. Importantly, the imaging agent detected endometriosis in 14 of 17 participants who were surgically confirmed to have the disease, including two cases of thoracic endometriosis – a rarer and often more challenging form to diagnose. No false positives were reported.

Notably, the imaging agent was able to detect lesions across all endometriosis subtypes, suggesting broad applicability. The scan was well-tolerated by patients, with high levels of acceptability reported.

Beyond Diagnosis: Monitoring and Treatment Response

The potential of 99mTc-maraciclatide extends beyond initial diagnosis. Researchers believe it could be a valuable tool for monitoring disease progression and assessing treatment response. Currently, it’s difficult to objectively determine whether a treatment is effective, relying largely on subjective reports of pain reduction. This new imaging agent could provide a quantifiable marker of treatment success, accelerating the development of novel therapies.

From Instagram — related to Fast Track Designation, Director of the Endometriosis

Dr. Tatjana Gibbons, lead author of the study from the University of Oxford, emphasized the significance of these findings, stating the agent offers “a highly promising diagnostic and monitoring tool, particularly for superficial peritoneal endometriosis, which is the most common and yet the hardest type of endometriosis to identify.”

Fast Track Designation and Future Outlook

The U.S. Food and Drug Administration (FDA) has granted 99mTc-maraciclatide Fast Track Designation, recognizing the urgent need for improved diagnostic tools for endometriosis. Serac Healthcare, the company developing the agent, is preparing to initiate Phase III multi-center international studies later this year. These larger trials will be crucial to validate the Phase 2 findings and pave the way for regulatory submission.

Professor Christian Becker, Co-Director of the Endometriosis CaRe Centre in Oxford, highlighted the potential impact, stating that if Phase III results are positive, the agent “could both reduce diagnostic delays and provide a validated endpoint for the development of new therapeutics.”

The Rise of Molecular Imaging in Women’s Health

The development of 99mTc-maraciclatide represents a broader trend towards the use of molecular imaging in women’s health. Traditional imaging techniques often lack the sensitivity to detect early-stage disease or subtle changes in disease activity. Molecular imaging, which targets specific biological processes, offers the potential for earlier and more accurate diagnoses, leading to more effective and personalized treatment strategies.

New endometriosis research shows promise in diagnosing patients non-invasively

Professor Krina Zondervan, Co-Director of the Endometriosis CaRe Centre, noted that if confirmed in larger studies, imaging with maraciclatide “could transform clinical research and practice and potentially empower the development of treatments for women across the globe.”

FAQ

Q: What is endometriosis?
A: Endometriosis is a condition where tissue similar to the lining of the uterus grows outside of it, causing pain and inflammation.

Q: What is 99mTc-maraciclatide?
A: It’s a novel molecular imaging agent that helps visualize endometriosis lesions without the need for surgery.

Q: Is this imaging agent currently available?
A: No, it is still under development and undergoing Phase III clinical trials.

Q: What is Fast Track Designation?
A: It’s a designation by the FDA that expedites the development and review of drugs for serious conditions.

Q: What is SPECT-CT imaging?
A: SPECT-CT (Single-Photon Emission Computed Tomography-Computed Tomography) is an imaging technique that combines two different types of scans to provide detailed images of the body.

Did you know? Endometriosis can take an average of 7-10 years to diagnose from the onset of symptoms.

Pro Tip: If you suspect you may have endometriosis, it’s key to consult with a healthcare professional for proper evaluation and diagnosis.

Stay informed about the latest advancements in endometriosis research and treatment. Endometriosis UK is a valuable resource for patients and healthcare professionals alike.

Do you have questions about endometriosis or this new imaging agent? Share your thoughts in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

‘Lightning bum’ is the shock symptom striking Brits several times a month

by Chief Editor
written by Chief Editor
If you get butt pain you might want to take notes (Picture: Getty)

Experiencing a sudden, sharp zap of pain shooting into your rectum? You’re not alone. Increasingly, Brits are reporting this sensation, dubbed ‘lightning bum’ – a surprisingly common, yet often underreported, medical phenomenon.

What Exactly *Is* Lightning Bum?

Doctor Hana Patel describes ‘lightning bum’ as a ‘sudden, sharp, electric shock-like pain in and around the rectum.’ These sensations are typically brief, lasting only seconds, but can be intensely painful. Medically, the pain often stems from spasms of the anal or pelvic floor muscles. It can even feel like a severe muscle cramp that quickly subsides.

Why is Lightning Bum on the Rise?

While definitive numbers are lacking due to underreporting, doctors are seeing more cases. It’s more frequently reported in women, potentially linked to gynaecological conditions, hormonal fluctuations affecting nerve sensitivity, and pregnancy. However, men can experience it too.

The Connection to ‘Lightning Crotch’

The sensation isn’t limited to the rectal area. ‘Lightning bum’ shares similarities with ‘lightning crotch’ – a common pregnancy symptom – as the pain can radiate into the lower pelvis, vagina, tailbone, legs, or lower abdomen.

What Health Issues Could Lightning Bum Signal?

While often harmless on its own, ‘lightning bum’ can sometimes indicate an underlying health issue. Here are some potential causes:

  • Proctalgia Fugax: A spasm of the anal sphincter muscle, affecting up to 18% of people aged 30-60. Treatment focuses on muscle relaxation.
  • Endometriosis: Can cause rectal pain, particularly around menstruation, due to lesions irritating pelvic nerves.
  • Pelvic Floor Spasms: Involuntary muscle contractions that can be addressed with physiotherapy.
  • Irritable Bowel Syndrome (IBS): May contribute to rectal discomfort.
  • Nerve Compression Syndrome: A trapped or squeezed nerve, potentially treatable with physical therapy or medication.
  • Sexually Transmitted Infections (STIs): Infections like gonorrhoea, chlamydia, and herpes can cause rectal inflammation and pain.

Treating the Zap: What Can You Do?

If ‘lightning bum’ is persistent, consulting a GP is crucial to identify any underlying causes. However, several at-home remedies can provide relief:

  • Warm baths and heat packs
  • Relaxation and breathing techniques
  • Pelvic floor physiotherapy
  • Avoiding constipation
  • Gentle stretching or yoga

More on your health and wellness…

Don’t suffer in silence. While discussing ‘lightning bum’ might feel awkward, seeking medical advice and exploring treatment options can significantly improve your quality of life.

0 comments
0 FacebookTwitterPinterestEmail
Health

Say no to pain, period: Stigma delaying endometriosis treatment | Bengaluru News

by Chief Editor
written by Chief Editor

The Silent Struggle: Why Endometriosis Awareness Needs a Revolution

Bengaluru, and cities like it, are seeing increased diagnoses of endometriosis, particularly among young women. Yet, a significant hurdle remains: the delay in seeking treatment. Doctors report that societal stigma surrounding menstrual health and a reluctance to address pain contribute to a diagnostic delay of six to eight years from the onset of symptoms.

Normalizing Pain: A Dangerous Trend

The normalization of painful periods is a core issue. Many women are raised with the expectation that period pain is simply a part of life, a burden to be endured silently. This belief, passed down through generations, prevents individuals from recognizing that debilitating pain isn’t normal and warrants medical attention. As Dr. Madhuri Vidyashankar P of Motherhood Hospitals notes, women often hesitate to even grab over-the-counter pain relief, fearing it’s a sign of weakness.

The Far-Reaching Impact of Endometriosis

Endometriosis isn’t just about painful periods. It’s a chronic condition where tissue similar to the uterine lining grows outside the uterus, causing inflammation and pain. This can affect multiple aspects of a woman’s life. Dr. Nidhi Nandan, Sakra World Hospital, emphasizes the condition’s impact on physical health, fertility, and mental well-being. Chronic pelvic pain, severe cramps, and fatigue can disrupt daily activities and productivity. The emotional toll of undiagnosed endometriosis, particularly concerning fertility and intimate relationships, can be substantial.

Untreated endometriosis can lead to chronic pelvic pain, ovarian cysts, and pelvic adhesions. In advanced stages, it can even affect the bowel, bladder, ureters, and pelvic nerves, making treatment significantly more complex, according to Dr. B Ramesh of Altius Hospital.

Future Trends: Early Detection and Personalized Treatment

The future of endometriosis care is likely to focus on earlier detection and more personalized treatment approaches. Increased awareness campaigns, particularly targeting younger generations, are crucial. These campaigns need to destigmatize menstrual health and empower women to advocate for their own health.

Technological advancements are also playing a role. Non-invasive diagnostic tools are being developed to detect endometriosis earlier and more accurately. Laparoscopic surgery, as demonstrated by successful cases at Altius Hospital, offers a minimally invasive treatment option with faster recovery times. A recent Instagram post highlighted a painlessly performed fibroid surgery using laparoscopy at Altius Hospital.

Personalized medicine, tailoring treatment to the individual’s specific needs and the severity of their condition, is also gaining traction. This may involve a combination of medication, lifestyle changes, and surgical interventions.

The growing number of endometriosis cases treated at Altius Hospital in Bangalore suggests a rising awareness and a center of expertise for complex surgeries.

What’s Changing in Patient Care?

The approach to endometriosis is evolving. There’s a growing recognition that listening to patients’ experiences and validating their pain is paramount. Doctors are increasingly adopting a holistic approach, addressing not only the physical symptoms but also the emotional and psychological impact of the condition.

Online communities and support groups, like those discussed on Reddit, are also providing valuable resources and a sense of community for women living with endometriosis.

FAQ

What is endometriosis? Endometriosis is a chronic condition where tissue similar to the uterine lining grows outside the uterus, causing inflammation and pain.

Why is there a delay in diagnosis? Stigma surrounding menstrual health and the normalization of painful periods often lead to delays in seeking medical attention.

What are the symptoms of endometriosis? Symptoms can include chronic pelvic pain, severe menstrual cramps, fatigue, and difficulty with fertility.

Is there a cure for endometriosis? Currently, there is no cure, but treatments can help manage symptoms and improve quality of life.

Where can I identify endometriosis treatment in Bangalore? Altius Hospital specializes in endometriosis treatment and can be reached at +91 99728 999 99.

Did you know? Endometriosis is estimated to affect about 10% of women of reproductive age, but the actual prevalence may be higher due to underdiagnosis.

Pro Tip: Don’t dismiss severe or persistent pelvic pain as “just a bad period.” Seek medical advice to rule out endometriosis and other potential causes.

Have you been affected by endometriosis? Share your story in the comments below. Explore our other articles on women’s health for more information. Subscribe to our newsletter for the latest updates and insights.

0 comments
0 FacebookTwitterPinterestEmail
Health

Doctors Dismissed My Symptoms for Years—Now I Help Other Women Get Answers 

by Chief Editor
written by Chief Editor

The Long Road to Diagnosis: Why Women’s Pain is Still Dismissed

For years, Sophie Richards’s debilitating pain was dismissed as “dramatic” or simply “bad periods.” Her story, recently highlighted in Newsweek, is tragically common. It underscores a critical issue in healthcare: the systemic dismissal of women’s pain and the lengthy, often frustrating, journey to a proper diagnosis. Richards’s experience, ultimately revealed as endometriosis, is a stark reminder of the require for greater awareness, improved medical education, and a shift in how women’s health concerns are addressed.

The Endometriosis Delay: A Decade of Suffering

Endometriosis affects roughly 1.5 million people in the U.K. And 10-15% of women of reproductive age in the U.S. Despite these numbers, diagnosis often takes seven to ten years. This delay isn’t simply inconvenient; it can have devastating consequences for women’s physical and mental health, impacting their education, careers, and overall quality of life. Richards’s story exemplifies this, as her symptoms interfered with her studies and led to years of feeling unheard and ashamed.

Misdiagnosis and the Cycle of Doubt

The path to diagnosis is often riddled with missteps. Richards faced suggestions that her symptoms were due to a sexually transmitted disease, leading to feelings of humiliation and further distrust in the medical system. This highlights a dangerous pattern: when women’s pain isn’t readily explained, it’s often attributed to psychological factors or lifestyle choices, rather than being taken seriously as a potential physical ailment. The normalization of “bad periods” also contributes to the problem, leading many women to believe their pain is simply something they must endure.

The Power of Self-Advocacy and Research

Frustrated with the lack of answers, Richards took matters into her own hands, embarking on extensive self-research. She discovered the connection between her symptoms and inflammation, leading her to explore various dietary and lifestyle changes. This proactive approach, while empowering, shouldn’t be necessary. It underscores the need for doctors to be better equipped to recognize and diagnose conditions like endometriosis promptly.

The Role of Inflammation in Chronic Conditions

Richards’s journey revealed that addressing the underlying inflammation was key to managing her symptoms. This aligns with growing research highlighting the role of inflammation in a wide range of chronic conditions, not just endometriosis. An anti-inflammatory lifestyle, focusing on diet, gut health, exercise, sleep, stress management, and detoxification, can be a powerful tool for improving overall health and well-being.

A Call for Education and Early Intervention

Richards advocates for comprehensive menstrual health education, starting at a young age for both boys and girls. She believes that destigmatizing conversations about periods and teaching individuals to recognize the difference between normal discomfort and potentially serious symptoms is crucial. Early education could empower individuals to advocate for themselves and encourage healthcare professionals to take women’s pain seriously.

Future Trends in Women’s Health

Several trends suggest a potential shift in women’s healthcare:

  • Increased Awareness: Advocates like Sophie Richards are raising awareness through social media and personal storytelling, challenging the status quo and demanding better care.
  • Focus on Holistic Approaches: There’s a growing interest in holistic approaches to women’s health, recognizing the interconnectedness of physical, mental, and emotional well-being.
  • Technological Advancements: New technologies, such as at-home hormone testing and symptom tracking apps, are empowering women to monitor their health and gather data to share with their doctors.
  • Specialized Training: Increased demand for specialized training in women’s health for medical professionals.

FAQ

Q: What is endometriosis?
A: Endometriosis is a chronic condition where tissue similar to the lining of the uterus grows outside the womb, causing inflammation and pain.

Q: Why does it take so long to diagnose endometriosis?
A: Symptoms are often dismissed or misdiagnosed, and awareness among healthcare professionals can be limited.

Q: Can diet and lifestyle changes help with endometriosis?
A: An anti-inflammatory lifestyle, focusing on diet, gut health, and stress management, can help manage symptoms.

Q: Where can I locate more information about endometriosis?
A: Resources like Endometriosis UK and the American Endometriosis Association offer valuable information and support.

Did you know? One in ten women in Wales suffer from endometriosis.

Pro Tip: Keep a detailed symptom diary to share with your doctor. This can help them identify patterns and build a more accurate diagnosis.

Share your story! Have you experienced delays in diagnosis or dismissal of your pain? Leave a comment below and let’s continue the conversation.

0 comments
0 FacebookTwitterPinterestEmail
Health

World Endometriosis Day: Symptoms, Fertility & New Diagnosis Approaches

by Chief Editor
written by Chief Editor

Understanding Endometriosis: Current Trends and Future Directions

Each year on March 14th, World Endometriosis Day serves as a crucial reminder of a chronic gynecological condition affecting an estimated 10-15% of women of reproductive age globally. Whereas awareness is growing, significant advancements are needed in diagnosis, treatment, and overall understanding of this complex disease.

The Evolving Diagnostic Landscape

For decades, laparoscopy was the gold standard for confirming endometriosis. However, a shift is underway towards earlier, clinical, and less invasive diagnostic models. This fresh approach emphasizes a thorough medical history, physical examination, and the utilization of imaging studies like transvaginal ultrasound with specific protocols and magnetic resonance imaging (MRI). This evolution aims to reduce unnecessary surgeries, shorten diagnostic timelines, and enable more personalized treatment plans.

Pro Tip: Don’t dismiss persistent pelvic pain. Advocate for yourself and seek a second opinion if your concerns aren’t being adequately addressed.

Endometriosis and Fertility: A Closer Look

The impact of endometriosis on fertility is a significant concern for many women. Studies indicate that 30-50% of women with endometriosis experience difficulties conceiving naturally. However, it’s important to note that 50-70% of patients can become pregnant spontaneously, depending on factors like age, the severity of the disease, and the condition of reproductive organs like the fallopian tubes and ovaries.

For those facing challenges, assisted reproductive technologies (ART) – including intrauterine insemination (IUI) and in vitro fertilization (IVF) – offer effective therapeutic alternatives.

The Importance of Early Detection

Recent scientific evidence highlights the critical role of early detection in preventing disease progression. While not all women with endometriosis experience infertility, a delayed diagnosis and subsequent progression can compromise ovarian reserve and reproductive function. Early diagnosis allows for timely intervention and the development of reproductive strategies tailored to each stage of life.

New Treatment Paradigms

Current treatment options include progestogens, which help reduce the effect of estrogen and limit the growth of endometrial tissue outside the uterus, thereby decreasing inflammation and pain. However, research is continually exploring new avenues for managing endometriosis.

Raising Awareness: Challenging the Normalization of Pain

Organizations worldwide are actively working to raise awareness and encourage early consultation. The “If it stops you, it could be Endometriosis” initiative emphasizes a vital message: intense menstrual pain should not be normalized. The Argentine Society of Endometriosis is actively working to improve the quality of life for patients and increase knowledge about the disease.

Did you know? The color yellow is internationally associated with endometriosis awareness and advocacy.

Future Trends and Research Directions

Several promising areas of research are emerging that could revolutionize endometriosis care:

  • Non-Hormonal Therapies: A growing focus on developing non-hormonal treatments to address the diverse needs of patients who may not be suitable candidates for hormonal therapies.
  • Personalized Medicine: Utilizing genetic and biomarker data to tailor treatment plans to individual patients, maximizing effectiveness and minimizing side effects.
  • Advanced Imaging Techniques: Continued refinement of imaging technologies, such as high-resolution MRI and novel ultrasound techniques, to improve diagnostic accuracy and non-invasive monitoring of disease progression.
  • Inflammation and the Immune System: Increased understanding of the role of inflammation and the immune system in the development and progression of endometriosis, leading to targeted therapies.

FAQ

Q: What are the main symptoms of endometriosis?
A: Symptoms can vary, but commonly include pelvic pain, painful periods, pain during intercourse, and chronic discomfort.

Q: Is endometriosis curable?
A: Currently, there is no cure for endometriosis, but treatments can effectively manage symptoms and improve quality of life.

Q: Can endometriosis affect fertility?
A: Yes, endometriosis can contribute to fertility challenges, but many women with the condition are still able to conceive.

Q: What should I do if I suspect I have endometriosis?
A: Consult with a healthcare professional for a proper diagnosis and discuss appropriate treatment options.

Desire to learn more about managing chronic pain? Explore our guide to chronic pain management.

Share your experiences with endometriosis in the comments below. Your story could help others feel less alone.

0 comments
0 FacebookTwitterPinterestEmail
Health

Fertility treatments linked to small increases in some cancers

by Chief Editor
written by Chief Editor

Fertility Treatments and Cancer Risk: What the Latest Research Reveals

A recent study published in JAMA Network Open has shed light on the complex relationship between medically assisted reproduction (MAR) and cancer risk in women. While overall cancer incidence among those who undergo fertility treatments remains comparable to the general population, certain cancer types appear to be slightly more common. This has sparked important conversations about long-term monitoring and personalized risk management for women who have utilized MAR.

Understanding the Rise of Medically Assisted Reproduction

Medically assisted reproduction is becoming increasingly prevalent, accounting for 6.7% of births in Australia in 2017. Treatments encompass a range of technologies, including in-vitro fertilization (IVF), intrauterine insemination (IUI), and ovulation induction using medications like clomiphene citrate. These procedures often involve hormonal manipulation and ovarian stimulation, raising questions about potential long-term health effects.

The Australian Cohort Study: Key Findings

Researchers in Australia conducted a population-based cohort study involving over 417,000 women who had undergone MAR treatment. The study compared cancer risks across three main MAR cohorts: ART (IVF/ICSI), IUI with ovarian stimulation, and ovulation induction with clomiphene citrate. The findings indicated that while all-cancer incidence was similar to the general population for ART and IUI/OS, there was a slight increase (4%) following clomiphene citrate treatment.

Specific Cancer Types Show Elevated Risk

The most notable increases in cancer risk were observed in specific types. Uterine cancer rates were elevated across all treatment groups – 23% higher after ART, 32% higher after IUI with ovarian stimulation, and a substantial 83% higher after clomiphene citrate. Ovarian cancer incidence was also higher in the ART and IUI/OS cohorts, increasing by 23% and 18%, respectively. Both in situ and invasive melanoma were more common, by 7% to 15%, across all cohorts.

Did you understand? The highest risk of uterine cancer following clomiphene citrate treatment was observed in women aged 18-35 years and within the first year of treatment.

Decreased Cancer Risks Observed in Some Areas

Interestingly, the study also revealed lower risks of certain cancers among women who underwent MAR. Cancers of the lung and uterine cervix were less common. Cervical cancer risk was reduced by 39% to 48%, likely due to increased screening during infertility investigations. Acute myeloid leukemia also showed a decreased incidence across all MAR cohorts.

The Role of Infertility Itself

It’s crucial to acknowledge that underlying infertility may contribute to cancer risk. Women seeking MAR often have pre-existing conditions like endometriosis or polycystic ovarian syndrome, which are themselves associated with increased cancer risk. The study compared MAR patients to the general population, not to infertile women who did not pursue treatment, making it difficult to isolate the effects of the treatments themselves.

Future Trends and Research Directions

Several trends are likely to shape future research in this area:

  • Longer-Term Follow-Up: Current studies have relatively short follow-up periods. Longer-term monitoring is needed to assess cancer risks as women age and reach the ages where certain cancers become more prevalent.
  • Comparison Groups: Future studies should compare MAR patients to infertile women who do not undergo treatment to better understand the specific impact of the procedures.
  • Personalized Risk Assessment: Developing personalized risk assessment tools that consider individual factors like infertility diagnosis, treatment type, and family history could help identify women who may benefit from more intensive monitoring.
  • Genetic and Epigenetic Studies: Research into the epigenetic effects of MAR treatments may reveal mechanisms underlying any observed cancer risks.
  • Refined Monitoring Strategies: The findings may lead to refined monitoring strategies, such as earlier or more frequent screenings for specific cancer types in women with a history of MAR.

Pro Tip:

If you have undergone MAR, discuss your individual risk factors with your healthcare provider and ensure you are up-to-date on recommended cancer screenings.

FAQ

Q: Does undergoing fertility treatment significantly increase my risk of cancer?
A: the increase in cancer risk is small. Still, certain cancer types, like uterine and ovarian cancer, may be slightly more common.

Q: What can I do to reduce my cancer risk after fertility treatment?
A: Discuss your individual risk factors with your doctor and follow recommended cancer screening guidelines. Maintaining a healthy lifestyle, including a balanced diet and regular exercise, is also important.

Q: Are all fertility treatments associated with the same level of risk?
A: No. The study found that risks varied depending on the type of treatment used, with clomiphene citrate showing the highest association with certain cancers.

Q: Should I be worried if I’ve had fertility treatment?
A: The absolute increases in risk are small. However, it’s important to be aware of the potential risks and discuss them with your healthcare provider.

Explore more articles on women’s health and reproductive medicine here.

0 comments
0 FacebookTwitterPinterestEmail
Health

The new 5-minute screening tool for endometriosis detection

by Chief Editor
written by Chief Editor

Endometriosis Detection: A 5-Minute Test Could Revolutionize Diagnosis and Treatment

For millions of women worldwide, the path to an endometriosis diagnosis is a long and arduous one, often taking six to eight years. But a new tool developed by researchers at the University of Queensland (UQ) promises to dramatically shorten that timeline. The Simplified Adolescent Factors for Endometriosis (SAFE) score, a 6-question questionnaire, offers a rapid, accessible way to identify individuals at risk and expedite specialist referrals.

The Diagnostic Delay: A Critical Issue

Endometriosis affects up to 11% of Australian women of reproductive age, and is characterized by tissue similar to the uterine lining growing outside of the uterus. This can lead to debilitating pelvic pain, heavy menstrual bleeding, and, for many, significant challenges with fertility. The lengthy diagnostic delay isn’t simply a matter of inconvenience; it impacts quality of life, career progression, and educational opportunities. As highlighted in The Conversation, the condition can even derail careers and education.

How the SAFE Score Works

The SAFE score is designed to be used in primary care settings. It assesses risk based on responses to six key questions: whether the patient experiences frequent pelvic pain, has sought treatment for it, uses painkillers for pelvic pain, experiences heavy menstrual bleeding or painful periods, and has a family history of endometriosis. The questionnaire utilizes a point-based system; a higher score indicates a greater likelihood of the condition. Professor Gita Mishra AO, Centre Director of UQ’s Australian Women and Girls’ Health Research Centre, emphasizes that the tool is applicable to women of all ages, but is specifically tailored to adolescents, ideally at the onset of menstruation.

Beyond Early Detection: Implications for Fertility

Early diagnosis isn’t just about alleviating pain; it’s also crucial for preserving fertility. Research indicates that many women are diagnosed in their late twenties, often when they are actively trying to conceive. Early identification allows for proactive management of potential fertility issues. Whereas ovulation induction is a common treatment, News-Medical reports that IVF may be a more effective option for women with endometriosis.

Future Trends and Developments

The development of the SAFE score represents a significant step forward, but research is ongoing. Next steps include evaluating the tool’s effectiveness in clinical settings, assessing its practicality in GP clinics and specialist centers, and exploring the potential for a dedicated mobile app. Experts are also working towards non-surgical diagnostic methods, aiming to replace the need for exploratory surgery with techniques like ultrasound or MRI.

increased awareness, particularly during Endometriosis Awareness Month (signified by the color yellow), is vital. Greater understanding of the condition can help normalize conversations about menstrual health and reduce the stigma surrounding endometriosis, encouraging more women to seek help sooner.

FAQ

Q: How long does the SAFE score seize to administer?
A: The questionnaire takes approximately 5 minutes to complete.

Q: Is the SAFE score a definitive diagnosis?
A: No, the SAFE score is a screening tool to identify individuals at risk who should be referred for further investigation.

Q: Who can administer the SAFE score?
A: The SAFE score is designed for use in primary care settings by GPs and other healthcare professionals.

Q: What are the common symptoms of endometriosis?
A: Common symptoms include pelvic pain, heavy menstrual bleeding, and painful periods.

Did you realize? The average diagnostic delay for endometriosis is 6-8 years.

Pro Tip: Don’t dismiss persistent pelvic pain as “just a bad period.” Advocate for your health and seek medical attention if you are concerned.

If you are experiencing symptoms of endometriosis, please consult with your healthcare provider. To learn more about endometriosis and available resources, visit the Endometriosis Foundation of America.

0 comments
0 FacebookTwitterPinterestEmail
Health

Simon Gordon’s endometriosis surgeries were gynaecology’s open secret. Now colleagues and patients are speaking out

by Chief Editor
written by Chief Editor

Melbourne Surgeon’s Practices Spark National Inquiry into Endometriosis Care

A Four Corners investigation has revealed troubling allegations against Melbourne surgeon Simon Gordon, who repeatedly performed surgeries on women for endometriosis despite pathology reports showing little to no evidence of the disease. The revelations have prompted a federal health minister to call for a Safer Care Victoria inquiry into Epworth Hospital’s management of Dr. Gordon, and a Medicare investigation into his billing practices.

Unnecessary Surgeries and Patient Harm

The investigation found that Dr. Gordon billed patients and Medicare for complex surgeries (item number 35641), designated for “severe” endometriosis, even when pathology results indicated mild or no endometriosis was present. Gynaecologists reviewing patient files have stated that many of these surgeries were unnecessary and potentially caused “more harm than good,” leading to increased pain and compromised fertility for patients.

Courtney Paton underwent seven surgeries with Dr. Gordon, ultimately resulting in the removal of both her ovaries and uterus. Pathology reports from these surgeries repeatedly showed no signs of endometriosis. Professor Thierry Vancaillie, a leading laparoscopic surgeon, described the removal of Courtney’s ovaries as unjustified.

Other patients, like Mary Spanos and Jess Foster, also received diagnoses of severe endometriosis from Dr. Gordon despite pathology reports indicating its absence. Mary Spanos discovered “NIL” endometriosis in her pathology reports, while Jess Foster experienced debilitating pain after surgery and was told by a fertility specialist that her ovary did not need to be removed.

Systemic Concerns and Hospital Response

Complaints about Dr. Gordon’s methods were made to Epworth Hospital management, AHPRA, and Victoria’s Healthcare Complaints Commission over the past five years. Despite these complaints, surgeries continued to be performed, and patients continued to experience adverse outcomes. Epworth HealthCare has commissioned an external review of its clinical governance arrangements.

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) expressed distress over the allegations and stated that Dr. Gordon is no longer a member of the college. RANZCOG acknowledged the harm experienced by patients and emphasized that the alleged conduct does not align with the college’s values.

Billing Practices Under Scrutiny

Federal Health Minister Mark Butler described the allegations as “sickening” and has requested a review of Dr. Gordon’s Medicare billing. The surgeon repeatedly charged Medicare for item 35641, reserved for severe endometriosis cases, when pathology reports did not support the diagnosis.

The Culture of Silence

Gynaecologists interviewed by Four Corners highlighted a culture of fear within the medical community, where concerns about colleagues’ practices are often suppressed due to potential career repercussions. Dr. Shamitha Kathurusinghe, a Melbourne-based gynaecologist, expressed concern about speaking up due to potential isolation and career impacts, particularly as a “brown female surgeon.”

Future Trends in Endometriosis Care and Surgical Oversight

Increased Scrutiny of Surgical Practices

The case of Dr. Gordon is likely to lead to increased scrutiny of surgical practices for endometriosis, with a greater emphasis on verifying diagnoses through pathology reports and second opinions. Hospitals may implement stricter protocols for reviewing complex cases and ensuring adherence to national guidelines.

Enhanced Mandatory Reporting Requirements

There is a growing call for stronger mandatory reporting requirements for clinicians and hospitals when concerns arise about a practitioner’s performance. Epworth Hospital’s CEO wrote to AHPRA, urging the regulator to provide timely notification of investigations to private hospitals, enabling them to manage risk and protect patients.

Empowering Patients and Promoting Shared Decision-Making

This case underscores the importance of empowering patients to actively participate in their healthcare decisions. Patients should be encouraged to seek second opinions, request access to their medical records (including pathology reports), and ask questions about their treatment plans. Shared decision-making, where patients and doctors collaborate on treatment options, will become increasingly crucial.

Advancements in Non-Surgical Treatments

As gynaecologists like Dr. Desiree Yap emphasize, there’s a growing shift away from viewing surgery as the sole solution for endometriosis pain. Research into non-surgical treatments, such as hormonal therapies, pain management techniques, and lifestyle modifications, is likely to accelerate, offering more women alternatives to invasive procedures.

FAQ

Q: What is endometriosis?
A: Endometriosis is a condition where tissue similar to the lining of the uterus grows outside of it, causing pain and potentially infertility.

Q: What is item number 35641?
A: It’s a Medicare item number for a complex surgery designated for severe endometriosis.

Q: What is AHPRA?
A: The Australian Health Practitioner Regulation Agency is the national body responsible for regulating health practitioners.

Q: What should I do if I have concerns about my endometriosis treatment?
A: Seek a second opinion, request your medical records, and discuss your concerns with your doctor.

Did you know? Severe, or “deep infiltrating endometriosis”, only affects about 20% of women with the disease.

Pro Tip: Always ask your doctor to explain the results of your pathology reports in detail and discuss all available treatment options.

Here’s a developing story. Share your thoughts in the comments below and explore more articles on women’s health on our website.

0 comments
0 FacebookTwitterPinterestEmail
Tech

Could sex on Zoom with strangers help me orgasm after years of pain? I tried bizarre celeb-loved therapy

by Chief Editor
written by Chief Editor

From Pain to Pleasure: The Rise of Neo-Tantra and Sexual Wellness

The quest for fulfilling sex is as old as time, but a modern approach – neo-tantra – is gaining traction, promising not just pleasure, but a deeper connection to self and partner. Driven by figures like Laura Walter, founder of Yoniverse, and embraced by celebrities like Sting and Gwyneth Paltrow, this isn’t your grandmother’s tantra. But what exactly *is* neo-tantra, and why is it resonating now?

Beyond the Myths: Understanding Neo-Tantra

For many, tantra conjures images of elaborate rituals and complex sexual positions. However, neo-tantra, as practiced by Walter, is a Westernized interpretation focusing on sexuality as a pathway to spiritual growth and personal transformation. It diverges significantly from traditional tantric practices. “It actually has little to do with the ancient practice of tantra,” Walter explains. “I work with what’s called neo-tantra, and they’re quite different.”

The core principle revolves around nervous system regulation, emotional expression, and self-embodiment. It’s about learning to inhabit your body fully, and to meet all sensations – even pain – with unconditional love and awareness. This approach is particularly appealing to those, like Ruby Deevoy, who have experienced sexual trauma or chronic pain conditions like vulvodynia, affecting up to 18 per cent of people with vulvas.

Addressing the Silent Epidemic of Sexual Pain

Deevoy’s story highlights a critical need. She struggled for years with debilitating vulvodynia, where sex felt like “shoving shards of glass” into her vagina. Traditional medical approaches often fall short, with tests revealing no physical cause. Deevoy believes her condition is linked to endometriosis, and compounded by past trauma. This represents where neo-tantra offers a different toolkit.

Experts emphasize that neo-tantric practices aren’t a substitute for medical assessment. Dr. Lakhani explains, “Tantric practice, mindful movement, and body awareness can sometimes be helpful because they encourage women to reconnect with their bodies in a safe and gentle way.” However, a medical evaluation is crucial.

The Power of Body Awareness and Nervous System Regulation

Walter’s workshops emphasize techniques to cultivate body awareness. Simple practices like mindful breathing, gentle self-massage, and focused attention on physical sensations – the wind on your skin, the feel of clothing – are foundational. The goal is to rewire the brain to recognize and appreciate pleasure, rather than associating the body with pain or anxiety.

A key component is understanding the “fight or flight” response, and its less-recognized counterparts, “freeze” and “fawn.” Learning to identify these states and consciously shift out of them is crucial for creating a safe and pleasurable sexual experience. Deevoy found that actively engaging her “fight” response – through physical release like roaring and pillow-smashing – helped her release pent-up tension and connect with her partner more authentically.

Tools and Techniques: Jade Eggs and Beyond

Some neo-tantric practices incorporate tools like jade eggs, intended to heighten awareness and strengthen pelvic floor muscles. However, caution is advised. Experts warn that inserting foreign objects into the vagina can increase the risk of infection and irritation. Alternatives, like medical-grade devices designed for vaginal health, are recommended.

The workshops often involve guided self-exploration, even with cameras and microphones off, encouraging participants to touch themselves and explore sensations without the pressure of performance or orgasm. The emphasis is on experiencing pleasure for its own sake, rather than viewing orgasm as the ultimate goal.

The Future of Sexual Wellness: A Holistic Approach

The growing popularity of neo-tantra reflects a broader shift towards holistic sexual wellness. People are increasingly seeking approaches that address not just the physical aspects of sex, but also the emotional, psychological, and spiritual dimensions. This trend is fueled by a desire for deeper connection, greater self-awareness, and more fulfilling relationships.

As more individuals share their stories, like Deevoy’s, and as practitioners like Walter continue to refine their methods, neo-tantra is poised to become an increasingly mainstream approach to sexual health and wellbeing.

Frequently Asked Questions

What is the difference between tantra and neo-tantra? Neo-tantra is a Westernized interpretation of traditional tantric practices, focusing on personal transformation and sexual wellness rather than complex rituals.

Is neo-tantra right for someone with a history of sexual trauma? It can be beneficial, but it’s essential to work with a qualified practitioner and prioritize safety and self-care.

Are jade eggs safe to use? Experts advise caution, as they can increase the risk of infection. Medical-grade devices are a safer alternative.

Is orgasm the goal of neo-tantric practice? No, the focus is on experiencing pleasure and connection, rather than achieving orgasm.

Where can I learn more about neo-tantra? Yoniverse offers workshops, retreats, and coaching: https://www.yoniverse-tantra.com/

0 comments
0 FacebookTwitterPinterestEmail
Health

Targeted uterine mRNA treatment boosts fertility outcomes in mice

by Chief Editor
written by Chief Editor

Revolutionizing Infertility Treatment: mRNA Nanoparticles Offer New Hope

For millions struggling with infertility, the path to parenthood is often fraught with challenges. Now, groundbreaking research from Johns Hopkins Medicine is offering a beacon of hope, utilizing the power of messenger RNA (mRNA) delivered via precisely engineered nanoparticles. This isn’t just incremental progress; it’s a potential paradigm shift in how we approach and treat conditions like endometriosis, Asherman syndrome, and even complications arising from assisted reproductive technologies (ART).

The Promise of Targeted mRNA Delivery

The core of this innovation lies in the ability to deliver therapeutic mRNA directly to the endometrium – the lining of the uterus. mRNA acts as a set of instructions, telling cells to produce specific proteins. In this case, researchers focused on GM-CSF (granulocyte-macrophage colony-stimulating factor), a protein believed to enhance embryo implantation by thickening the uterine lining. However, delivering GM-CSF directly has limitations due to its short lifespan and potential for unintended effects. The solution? Lipid nanoparticles (LNPs) – tiny, fatty capsules that protect the fragile mRNA and guide it to its target.

Early attempts at mRNA delivery faced a significant hurdle: off-target effects. Conventional LNPs tended to spread beyond the uterus, causing toxicity in organs like the liver and spleen. The Johns Hopkins team overcame this by “decorating” their LNPs with a peptide called RGD. RGD acts like a molecular address, binding to proteins specifically expressed on the endometrium during the crucial “window of implantation” (WOI) – the period when the uterine lining is receptive to an embryo. This targeted approach dramatically reduced side effects and boosted the concentration of GM-CSF in the uterus.

Did you know? The mRNA technology used in this research is the same foundation behind the highly effective COVID-19 vaccines, demonstrating its versatility and potential beyond infectious disease.

From Mouse Models to Human Potential

The initial studies, published in Nature Nanotechnology, were conducted on mice. The results were compelling: mice treated with the tailored mRNA-LNPs showed embryo attachment rates comparable to healthy mice, a 67% improvement over untreated mice with endometrial injury. Crucially, no toxicity was observed in the uterus or other organs. While mouse models aren’t a perfect replica of the human reproductive system, the window of implantation is remarkably similar, suggesting a strong potential for translation to human treatments.

The implications are significant. Currently, patients who fail to achieve pregnancy with ART have limited FDA-approved options. This research offers a potential new standard of care, providing a way to directly address endometrial issues that hinder implantation. The team is already exploring the delivery of other cytokines and growth hormones via LNPs, expanding the possibilities for treating a wider range of fertility challenges.

Beyond Infertility: Expanding the Therapeutic Horizon

The potential of this mRNA-LNP delivery system extends far beyond infertility. Researchers believe it could be applied to other endometrial disorders, including:

  • Endometriosis: A painful condition where uterine tissue grows outside the uterus. Targeted mRNA delivery could potentially reduce inflammation and improve endometrial receptivity.
  • Endometrial Cancer: LNPs could deliver therapeutic mRNA directly to cancer cells, minimizing systemic side effects.
  • Recurrent Miscarriage: Addressing underlying endometrial issues could improve the chances of a successful pregnancy.

Pro Tip: The precision of LNP targeting is key. Future research will likely focus on refining these “molecular addresses” to ensure even greater specificity and minimize any potential off-target effects.

Future Trends and Challenges

Several key trends are shaping the future of this field:

  • Personalized Medicine: Tailoring mRNA therapies to individual patients based on their specific genetic profiles and endometrial characteristics.
  • Advanced LNP Engineering: Developing LNPs with even greater targeting capabilities and improved biocompatibility.
  • Combination Therapies: Combining mRNA delivery with other ART techniques to maximize success rates.
  • Long-Term Safety Studies: Rigorous clinical trials are essential to assess the long-term safety and efficacy of these therapies.

One significant challenge remains: the complexity of the human menstrual cycle. While the window of implantation is conserved, other factors can influence endometrial receptivity. Further research is needed to understand these nuances and optimize treatment timing.

FAQ

Q: Is this treatment available now?
A: No, this research is currently in the preclinical stage. Human clinical trials are needed before it can become a widely available treatment.

Q: What are the potential side effects?
A: The research so far shows a significantly improved safety profile compared to traditional GM-CSF delivery, with minimal toxicity observed in animal models. However, potential side effects will need to be carefully evaluated in human trials.

Q: How does this differ from IVF?
A: This isn’t a replacement for IVF, but rather a potential adjunct therapy. It aims to improve endometrial receptivity, increasing the chances of success for patients undergoing IVF or other ART procedures.

Q: Will this work for all types of infertility?
A: It’s unlikely to be a universal solution. However, it holds particular promise for cases where infertility is linked to endometrial factors.

Reader Question: “I’ve struggled with recurrent miscarriage. Could this technology potentially help me?” This is a promising area of research, and future studies may explore the use of mRNA-LNP therapy to address endometrial issues that contribute to recurrent miscarriage. Consult with a reproductive endocrinologist to discuss your specific situation.

This research represents a significant step forward in reproductive medicine. By harnessing the power of mRNA and nanotechnology, scientists are paving the way for more effective, targeted, and personalized treatments for infertility and other endometrial disorders. The future of reproductive health is looking brighter than ever.

Explore further: Read the original article on News Medical. Learn more about reproductive health from the American Society for Reproductive Medicine.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts